Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Expression of mesenchymal and α-cell phenotypic markers in islet β-cells in recently diagnosed diabetes.

White MG, Marshall HL, Rigby R, Huang GC, Amer A, Booth T, White S, Shaw JA.

Diabetes Care. 2013 Nov;36(11):3818-20. doi: 10.2337/dc13-0705. Epub 2013 Sep 23.

2.

Diabetes mellitus is associated with an increased expression of resistin in human pancreatic islet cells.

Al-Salam S, Rashed H, Adeghate E.

Islets. 2011 Sep-Oct;3(5):246-9. Epub 2011 Sep 1.

PMID:
21750415
3.

Loss of β-Cell Identity Occurs in Type 2 Diabetes and Is Associated With Islet Amyloid Deposits.

Spijker HS, Song H, Ellenbroek JH, Roefs MM, Engelse MA, Bos E, Koster AJ, Rabelink TJ, Hansen BC, Clark A, Carlotti F, de Koning EJ.

Diabetes. 2015 Aug;64(8):2928-38. doi: 10.2337/db14-1752. Epub 2015 Apr 27.

4.

Increased vimentin in human α- and β-cells in type 2 diabetes.

Roefs MM, Carlotti F, Jones K, Wills H, Hamilton A, Verschoor M, Durkin JMW, Garcia-Perez L, Brereton MF, McCulloch L, Engelse MA, Johnson PRV, Hansen BC, Docherty K, de Koning EJP, Clark A.

J Endocrinol. 2017 Jun;233(3):217-227. doi: 10.1530/JOE-16-0588. Epub 2017 Mar 27.

PMID:
28348116
5.

Improvement of pig islet function by in vivo pancreatic tissue remodeling: a "human-like" pig islet structure with streptozotocin treatment.

Vériter S, Aouassar N, Beaurin G, Goebbels RM, Gianello P, Dufrane D.

Cell Transplant. 2013;22(11):2161-73. doi: 10.3727/096368912X657864. Epub 2012 Oct 8.

PMID:
23051152
6.

Normal glucagon signaling and β-cell function after near-total α-cell ablation in adult mice.

Thorel F, Damond N, Chera S, Wiederkehr A, Thorens B, Meda P, Wollheim CB, Herrera PL.

Diabetes. 2011 Nov;60(11):2872-82. doi: 10.2337/db11-0876. Epub 2011 Sep 16.

7.

Immunohistochemical study of α- and β-cell distribution in human pancreatic Langerhans islets of various types.

Proshchina AE, Savel'yev SV.

Bull Exp Biol Med. 2013 Oct;155(6):798-801.

PMID:
24288769
8.

Islet amyloid polypeptide in pancreatic islets from type 1 diabetic subjects.

Tomita T.

Islets. 2011 Jul-Aug;3(4):166-74. Epub 2011 Jul 1.

9.

Localization of dipeptidyl peptidase-4 (CD26) to human pancreatic ducts and islet alpha cells.

Augstein P, Naselli G, Loudovaris T, Hawthorne WJ, Campbell P, Bandala-Sanchez E, Rogers K, Heinke P, Thomas HE, Kay TW, Harrison LC.

Diabetes Res Clin Pract. 2015 Dec;110(3):291-300. doi: 10.1016/j.diabres.2015.10.010. Epub 2015 Oct 26.

PMID:
26515908
10.

Automated recognition and quantification of pancreatic islets in Zucker diabetic fatty rats treated with exendin-4.

Kakimoto T, Kimata H, Iwasaki S, Fukunari A, Utsumi H.

J Endocrinol. 2013 Jan 2;216(1):13-20. doi: 10.1530/JOE-12-0456. Print 2013 Jan.

11.

Alpha cell-specific Men1 ablation triggers the transdifferentiation of glucagon-expressing cells and insulinoma development.

Lu J, Herrera PL, Carreira C, Bonnavion R, Seigne C, Calender A, Bertolino P, Zhang CX.

Gastroenterology. 2010 May;138(5):1954-65. doi: 10.1053/j.gastro.2010.01.046. Epub 2010 Feb 2.

PMID:
20138042
12.

Distribution of pancreatic endocrine cells including IAPP-expressing cells in non-diabetic and type 2 diabetic cases.

Iki K, Pour PM.

J Histochem Cytochem. 2007 Feb;55(2):111-8. Epub 2006 Sep 18.

PMID:
16982850
13.

Paracrinology of islets and the paracrinopathy of diabetes.

Unger RH, Orci L.

Proc Natl Acad Sci U S A. 2010 Sep 14;107(37):16009-12. doi: 10.1073/pnas.1006639107. Epub 2010 Aug 26.

14.

Adult duct-lining cells can reprogram into β-like cells able to counter repeated cycles of toxin-induced diabetes.

Al-Hasani K, Pfeifer A, Courtney M, Ben-Othman N, Gjernes E, Vieira A, Druelle N, Avolio F, Ravassard P, Leuckx G, Lacas-Gervais S, Ambrosetti D, Benizri E, Hecksher-Sorensen J, Gounon P, Ferrer J, Gradwohl G, Heimberg H, Mansouri A, Collombat P.

Dev Cell. 2013 Jul 15;26(1):86-100. doi: 10.1016/j.devcel.2013.05.018. Epub 2013 Jun 27.

15.

Nesfatin-1 stimulates glucagon and insulin secretion and beta cell NUCB2 is reduced in human type 2 diabetic subjects.

Riva M, Nitert MD, Voss U, Sathanoori R, Lindqvist A, Ling C, Wierup N.

Cell Tissue Res. 2011 Dec;346(3):393-405. doi: 10.1007/s00441-011-1268-5. Epub 2011 Nov 23.

PMID:
22108805
16.

Growth factor signalling in the regulation of α-cell fate.

Kawamori D, Akiyama M, Hu J, Hambro B, Kulkarni RN.

Diabetes Obes Metab. 2011 Oct;13 Suppl 1:21-30. doi: 10.1111/j.1463-1326.2011.01442.x. Review.

PMID:
21824253
17.

Native pancreatic alpha-cell adaptation in streptozotocin-induced diabetic primates: importance for pig islet xenotransplantation.

Dufrane D, Maillart JF, Aouassar N, Goebbels RM, Guiot Y, Gianello P.

Xenotransplantation. 2009 May-Jun;16(3):152-63. doi: 10.1111/j.1399-3089.2009.00530.x.

PMID:
19566655
18.

Effects of common genetic variants associated with type 2 diabetes and glycemic traits on α- and β-cell function and insulin action in humans.

Jonsson A, Ladenvall C, Ahluwalia TS, Kravic J, Krus U, Taneera J, Isomaa B, Tuomi T, Renström E, Groop L, Lyssenko V.

Diabetes. 2013 Aug;62(8):2978-83. doi: 10.2337/db12-1627. Epub 2013 Apr 4.

19.
20.

Both PAX4 and MAFA are expressed in a substantial proportion of normal human pancreatic alpha cells and deregulated in patients with type 2 diabetes.

Bonnavion R, Jaafar R, Kerr-Conte J, Assade F, van Stralen E, Leteurtre E, Pouponnot C, Gargani S, Pattou F, Bertolino P, Cordier-Bussat M, Lu J, Zhang CX.

PLoS One. 2013 Aug 27;8(8):e72194. doi: 10.1371/journal.pone.0072194. eCollection 2013.

Supplemental Content

Support Center